Alnylam Pharmaceuticals
ALNY
#629
Rank
ยฃ29.57 B
Marketcap
ยฃ221.49
Share price
0.67%
Change (1 day)
7.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company